Merck administers dose to first patient in Phase III study of Oral Cladribine in Generalised Myasthenia Gravis (gMG) Read more
Future-proofing pharma manufacturing: How companies and associations are upskilling to meet new challenges Read more
CDSCO reports low failure rate in cough syrup testing amid enhanced supply chain monitoring Read more
COPD diagnosed prevalent cases across 7MM to reach 38.02 million in 2033, forecasts GlobalData Read more
Abaloparatide approval to enhance osteoporosis treatment landscape for high-risk patients in UK: GlobalData Read more